chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID-19 Disease - Test positive 12/19/22 at SNF.   mild symptoms.  Remdesivir therapy completed.  - end isolation 12/31/22 per ID rec
When I come in contact with cold water my hands will swell and have a rash. Once my skin warms back up the rash goes away. Has been happening since the shot.
Mother brought daughter in for Covid booster.  Mother gave the clerk covid record card that had one vaccine given 06/01/2021 and the 2nd one was dated 07/02/2021.  Mother completed consent form and signed.  Covid record card was clipped to consent and given to me.  Pt "s name and date of birth verified with pt with mother present.  Covid vaccine was given to pt and she was instructed to stay in waiting room for 15 minutes.   AT the end of 15 minutes the mom approached the clerk and stated that she forgot that the pt had had covid booster last week  at this unit and presented the 2 nd card to the clerk.  The pt had been given the booster on 07/07/2022 at this Unit.  The clerk informed me and I called RN and reported the event.  I  was instructed to reassure the mother that the daughter might only have possibly more injection site soreness and body aches due to having 2 nd booster.  Mother was informed that the Private was contacted she is calling with her information.  Gave mother a copy of Vsafe and instructed her that she can call give them her information and that they can follow her by phone.  The patient was asked why she didn't tell the me about getting the booster last week and she replied that she thought it was a flu shot and then she stated that she thought it was the last one.  Mom stated that she has four children and that she forgot that she had brought her in for the booster last week and forgot to give the clerk the other  card.  I took both covid record cards and added all of them to only one card and kept the other card for disposal.
Slight sore arm; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 01-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient received dose of Shingles vaccine and experienced only a slight sore arm. The patient highly recommended this vaccine to all those 50 and older. Additional supportive information: The follow-up would not possible, as no contact, details were available.
Shingles; This case was reported by a nurse via call center representative and described the occurrence of shingles in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 2G2T7, expiry date unknown) for prophylaxis.   On 3rd September 2019, the patient received Shingrix (intramuscular). In September 2019, less than a week after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional information received were as follows: The nurse reported that the patient received Shingrix on left deltoid and experienced shingles. The healthcare professional did not had the expiry date.
Fever 102.5; red/pain injection site and 4" below; pain/swelling under arm; sore throat, running nose, headache; nausea/pain, diarrhea; very ill 6 days.
I developed Type I Diabetes shortly after being fully vaccinated.  Earliest symptoms began on May 21, 2021.  Confirmed diagnoses on June 23, 2021 with visit to Emergency Room and diagnosed with diabetic ketoacidosis.  I do not know if the Type I Diabetes diagnosis is a direct symptom of receiving the vaccine, but I am reporting in case others are seeing the same side effect.
Patient came into the pharmacy and  requested influenza seasonal vaccine.  He was advised that we did not have High dose and he requested the regular seasonal vaccine which was administered to him.  Agency website reporting  records indicated that  patient had received High dose earlier.  Patient stated that he has not received any flu shot this year and he reported no adverse effect  from his flu shot.
13 days after patient presented with measles like exavithem, no respiratory symptoms. Follow up on 08/04/02: "Manufacturer vaccine # and Lot # not available at this time."
Contracted a serious case of bronchitis for first time in my life.  Cleared with antibiotic in two week period.  Reoccurred once again in early May 2023.  Again healing with antibiotic treatment.  No idea whether a direct or indirect result of having Covid in early August 2022, or from the Moderna injections received in May and Sep 2022.
Intussusception, increased screaming, vomit, deep sleep.  5/4/07 Received vax records from PCP which reveal the following also received on 4/21/07: DTaP C2552AA 3rd dose Hib UE981AA 3rd dose IPV 20547 3rd dose PCV B086820 3rd dose Rotavirus 0389F 3rd dose 6/19/07 Received ER records.  No D/C Summary available.  Patient seen only in ER on 4/30/07 for vomiting & increased sleepiness. FINAL DX: Intussusception, reduced by air contrast enema.
The patient received Moderna on 4/29/2021 as an IM injection. The patient was due to receive a second dose and was inadvertently given Johnson and Johnson as a second shot on 6/29/2021.  We immediately recognized.  A medical physician and nurse called and spoke with patient's daughteron a virtual call. The home health  nurse was also present, Comfort. The patient's vital signs were stable before and after the vaccine was administered.   We have a plan to contact the patient weekly for the next four weeks to ensure he has no adverse reactions. We will also send a new vaccination card with the correct information.
Client resides at a homeless shelter and requested vaccine. Unknown to staff, he was vaccinated with 1 dose of Pfizer on 3/24/2021. No adverse reaction are known.
Pt recvd 1 dose of Engerix-B on 8JUN92 & w/in 24 hrs devel erythema & papular eruption on inner thighs & inner arms; 12JUN92 there were more eruptions; required MD visit; tx w/Seldane & topical antipruritic;
This case was reported by a healthcare professional and described the occurrence of unilateral hearing loss in a 48-year-old male subject who was vaccinated with HEPATITIS B vaccine (manufacturer unspecified). On unspecified dates the subject received the 1st dose, 2nd dose and 3rd dose of a Hepatitis B vaccine (unknown). At an unspecified time after receiving the 1st dose of Hepatitis B vaccine, the subject experienced unilateral hearing loss, which resolved after an unspecified period of time. The subject continued with the Hepatitis B vaccination series and no hearing loss was noted after receiving the 2nd and 3rd doses of the vaccine. At an unspecified time after completion of the Hepatitis B vaccination series, serological testing showed that the subject was not responding to therapy. The reporting nurse stated that she did not know when or where the subject received the Hepatitis B vaccination series, as the doses were not administered at this physician's office. In addition, the nurse did not know the vaccine tradename, if the next doses of the vaccine were delayed, nor when the titers were drawn. This case was assessed as medically serious by GSK. At the time of reporting, the unilateral hearing loss was resolved, but the outcome of not responding to therapy was unspecified.
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 08/27/2021. PATIENT FULLY VACCINATED ON 04/21/2021.
Patient reported adverse event one hour after vaccination via phone. Patient is a NP that works in Urgent Care setting. Patient stated that she did not have any concerns with receiving the vaccine and did not feel anxious before or during vaccination. Patient did not appear anxious before or during the vaccination per Nurse. Patient reported that approx. 10 minutes after vaccination while in her 15 minute monitoring period she felt a sudden onset of tachycardia. Patient states that she did not count her pulse but felt like at least 120 beats /min while at rest and lasted approx.  2 minutes. Episode stopped before her 15 minute monitoring period was up. No other symptoms present. Patient did not report tachycardia to any HD staff before leaving the HD. Patient had one other episode of sudden onset tachycardia while driving home that lasted approx. 2 minutes. Approx. 1 hour after vaccination patient was home and took Benadryl 25mg and repeated again at 3pm and 9pm on 01/04/2021 due to intermittent episodes of tachycardia on 01/04/2021. No further episodes of tachycardia reported. On 01/05/2021 patient reports feeling very anxious and took hydroxyzine that night to manage strong feeling of anxiety. Patient cancelled a scheduled trip the next day due to high anxiety and was evaluated by her PCP on 01/07/2021. PCP ordered Celexa due to high anxiety since episodes of tachycardia. Patient cancelled her Moderna COVID 19 second dose.
pt recv vax 1SEP95 & 12JUN96 pt exp severe case of chicken pox w/lesions &  w/itching & an assoc fever as high as 102;to med ctr & tx w/med;MD confirmed chicken pox;
21OCT96 numbness began in rt hand AM then tingling in feet in PM;22OCT96 numbness in lt hand & going up legs;went to clinic;25OCT96 could not walk;had MRI & echo;28OCT96 referred to MD & adm to hosp;
Facial Swelling and Facial Redness relieved by one dose of oral Benadryl.
Later in the evening after receiving vaccine pt has some swelling, in the morning had redness and hardening of area along with fever of 100.5 and itchiness. Advised Benadryl, Tylenol, cold compresses and observation.
Large red area on upper left arm. Looked like she had been hit by a baseball. Area is dark red, raised, warm, dry, slightly itchy in the center with a lighter red ring around it. Next day (1/17/10) the area had moved down the arm about one-half inch closer to elbow and expanded slightly at the bottom. Next day (1/18/10) area is in the same position and top of the area is turning dark purple. No sign of fever and no change in behavior or eating habits.
Fever, general malaise, extreme fatigue, aches in muscles and joints.  Began late evening the day of the injection, about 6-7 hours after. Lasted a little over 24 hours.
This case was reported by a healthcare professional and described the occurrence of swelling in a child subject (4 to 6) of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of KINRIX (unknown).  At an unspecified time after vaccination with KINRIX, the subject experienced swelling.  At the time of reporting the outcome of the event was unspecified.  It was reported that two subjects in the same clinic experienced swelling after getting KINRIX.  The linked case number is A0803170A.
Pt reported feeling his pulse was racing 15 minutes after vaccination. Refused medical care and left observation area.
I been nauseous since November 1st non stop. I was prescribed Ondansetron 4mg twice. I can't eat without it. I'm sick like I'm pregnant.
Swelling tongue, swelling throat, numbness on face,  lips, headache nausea, numbness feet, numbness hands
Headache, Fever, arm pain, chills, body aches (unspecified), swollen glands Narrative:
Severe and debilitating sinus infection accompanied by fever, chills, and headache. Symptoms may have been exacerbated due to allergic reaction to neomycin. After-effects and pain and swelling in arm continue as do the symptoms of sinusitis. Consultation with doctor over concern about allergic reaction.
REDNESS AND RED RASH NOTED AT IMMUNIZATION SITE.  ITCHING, SHAKY, NAUSEA, VOMITTING AND  TIREDNESS.  SEEN BY MEDICAL DIRECTOR.  BENADRYL 50MG BY MOUTH EVERY 6 HRS FOR 24 HOURS.  CLIENT WILL FOLLOW UP WITH CLINIC IF SYMPTOMS WORSEN OR PERSISTS.
Patient tolerated the vaccine well with no apparent side effects.   Ten days later awoke 12:30 AM with severe chest and upper back pain, presented to Med Center where he was found to have an Acute Coronary Syndrome. Transferred to Medical Center where he underwent successful PCI with two drug eluting stents for a 99% mid-LAD stenosis
patient received vaccine on 6/29/23. Patient reported to the pharmacist on 7/6/23 saying she had redness swelling around site and fevers. patient stated she had hard time breathing so she went to the ER which they admitted her for pneumonia or UTI based infection. This seems likely she had a concurrent infection manifesting when she came in but reported to us on 7/6/23 about an adverse event and this issue so we are reporting it.  Patient was told that fever redness and swelling is common but the breathing issues is not. We have no access to hospital notes and per patient stating it maybe due to vaccine we are submitting this report
On 05/21/2022, I did a home test that tested positive, so I went to a clinic to get the PCR COVID-19 test and the results were positive. On 05/25/2022 I started to feel symptoms. The were minor sinus congestion followed by minor chest congestion. I treated it with it with Advil, antihistamine and cough medicine, all over the counter. I received a prescription for Paxlovid, I did not take it because the symptoms were not bothersome enough that required it. The symptoms were fully resolved by 05/30/2022.
After the patient received Covid vaccine, she started experiencing itching.  The nurse monitoring the patient noticed she was scratching.  The patient continued to itch during the 15 minute observations period but no other adverse effects were noticed.  The observation period was extended to 30 minutes and then the patient was released.  An hour after she left the vaccination site she experienced an episode of vomiting which resolved.  Her husband noticed her to be pale upon returning home.  Later that night the patient was visibly shaking and had another episode of vomiting.  All symptoms have since resolved.
Patient came for appointment to get a booster of Moderna. Technician administered vaccine dose from a vial that was left over night at room temp. It was punctured on 12/22/21 at 9:33am therefore patient received dose from vial that was 25 hours after first punctured. Manufacture was contacted for further guidance. They responded that lot number was tested against covid activity for past time excursion and it still held protection activity for covid. pt was made aware and will not received additional dose.
pt recv vax DEC91 & in SEP93 pt was told had anti-HBs but not if it was a protective level; 26JAN94 recv a letter from hosp stating that had pos core & anti-HBS but not quantitative level; eval on 9FEB94 revealed a pos hep antigen;
eye inflammation, decreased vision, headaches - condition lasting months and ongoing at this time (9 months post vaccine)
Patient developed flu-like symptoms the day after the injection.  She subsequently noticed an axillary rash on the left side, which was not contiguous with the injection site.  The rash consisted of a large area of confluent erythema with several bullae.  Biopsy was performed by dermatology showing many eosinophils consistent with an allergic reaction.  The patient had not received any additional vaccinations or new medications at the time of or shortly prior to onset.
one day of fatigue, then 2 1/2 weeks later sore muscles, chills, headache, tight chest. Fever developed. Subsiding now at 3 1/2 weeks.
abdominal pain, hematuria, nausea, vomiting for 2 weeks. Has had 4 ED visits and continued pain despite negative workup.
This spontaneous case, initially received from pharmacist on 10-Oct-2018, concerns a 70-year-old, elderly male patient. The patient had no historical condition. The patient did not receive any concomitant medication. On 10-Oct-2018, the patient was administered with FLUAD (TIV) [dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 250794 and expiry date: 30-Apr-2019]. On the same day, the pharmacist thought that he was administering PNEUMOVAX and instead gave another dose of FLUAD (TIV) (dose: 0.5 ml route of administration: intramuscular, anatomical location: right deltoid, batch number: 250794 and expiry date: 30-Apr-2019). The reporter wanted to know if there was any information or studies where the patient received more than the recommended dose. The patient had not experienced any adverse event. The reporter assessed the case as non-serious. Non-significant follow-up received from the pharmacist on 30-Oct-2018: It was reported that the patient had not experienced any adverse event after vaccination. The reported also confirmed the vaccination date to be 10-Oct-2018. Narrative was amended accordingly.
On 09/30/2022 In the morning as soon as I woke I had fatigue more then usual, body aches, chills, mild fever, runny nose, headaches,  and ear pressure, I tested my symptoms to my doctor and he sent a  prescription of Paxlovid for 5 days. Am still taking medication.
Difficulty breathing, resulting in panic attack, requiring emergency room visit at 2:00am, Ativan injection. Subsequently panic attacks over period of 6-8 weeks, requiring medication (Ativan tablets). This was the first panic attack experienced in my life. I would be too terrified to ever take another flu shot.
Information has been received from a physician concerning a female (age unknown), who on approximately 10-AUG-2007, was vaccinated with a 0.5mL first dose of Gardasil.  Subsequently, the patient experienced a numb tongue.  The patient sought unspecified medical attention.  The patient recovered on an unspecified date.  No product quality complaint was involved.  Additional information has been requested.
Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a dose of Recombivax HB. Subsequently the patient developed tachycardia. Unspecified medical attention was sought. Subsequently, the patient recovered without requiring treatment. No further information was provided. There was no product quality complaint involved. Additional information has been requested.
really bad gas/severe amount of gas; pain in lower stomach/brick in his stomach; He felt really sick; it also affected when he went to go urinate/felt a little bit of pressure and almost pain with that; "troubles that night with [his] stomach"; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 69 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 09Mar2021 09:30 (Lot number: EN6204) at the age of 69 years as dose 1, 0.3 ml single for covid-19 immunisation. Relevant medical history included: "He tested positive for covid", start date: 04Jan2021 (unspecified if ongoing); "allergic to shellfish" (ongoing); "He puts his glasses on" (unspecified if ongoing); "He is allergic to topical propylene glycol" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Codeine, reaction(s): "allergic to codeine"; Vitamin e, reaction(s): "allergic to topical vitamin e". The following information was reported: CONTRAINDICATED PRODUCT ADMINISTERED (non-serious), outcome "unknown", described as "he noticed that one of the ingredients in the vaccine is polyethene glycol. He is wondering if that is his problem."; GASTRIC DISORDER (non-serious) with onset Mar2021, outcome "unknown", described as ""troubles that night with [his] stomach""; FLATULENCE (non-serious) with onset 09Mar2021, outcome "recovering", described as "really bad gas/severe amount of gas"; ABDOMINAL PAIN UPPER (non-serious) with onset 09Mar2021, outcome "recovering", described as "pain in lower stomach/brick in his stomach"; ILLNESS (non-serious) with onset Mar2021, outcome "unknown", described as "He felt really sick"; DYSURIA (non-serious) with onset Mar2021, outcome "unknown", described as "it also affected when he went to go urinate/felt a little bit of pressure and almost pain with that". Therapeutic measures were taken as a result of flatulence, abdominal pain upper. Additional information: The patient took Gas X as treatment and it worked. Patient had no prior vaccinations within 4 weeks and had no adverse events following prior vaccinations. Patient is allergic to topical propylene glycol and he noticed that one of the ingredients in the vaccine is polyethene glycol. He wanted to know if that is his problem and is asking if he should take the second dose.   No follow-up attempts are possible. No further information is expected.
Stroke; Couldn't walk; Blood pressure was higher than the caller had ever heard of it being; Can't walk; His legs are numb; Has no control of his legs; Heartrate was elevated; Dizziness; This is a spontaneous report from a contactable consumer (Patient's wife). An 86-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and Lot number EWO169), via left arm on 11May2021 as single dose for COVID-19 immunization. The patient's medical history included Thyroid. The patient's concomitant medications included Levothyroxine, Tamsulosin Hydrochloride (FLOMAX), Dutasteride, Aspirin81. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and Lot number ER8731), via left arm on 20Apr2021 as single dose for COVID-19 immunization. On an unknown date in 2021, the patient experienced blood pressure was higher than the caller had ever heard of it being. On 28Jun2021 he experienced dizziness and lightheadedness and last night his heartrate was elevated but that resolved when he woke up. She reports that he had an eye appointment and walked in there fine but when at home she heard a crash and she saw him with his hand out on the wall, he had not fallen but she helped him get to a chair. On 29Jun2021 patient had Elevated heartbeat 30Jun2021 he suddenly could not walk his legs were numb and he has no control of his legs. On 01Jul2021 patient could not walk, on 02Jul2021 he had Stroke. She reports that they have a zoom appointment with his doctor at 3pm but when she spoke with the nurse, she was advised to take her husband to the emergency room within the hour. They have not gone to the emergency room. She reported that there was an urgent care across the street, but she could not get him to walk to be able to get there. She reported that she heard that there were people with bell's palsy and neurological problems that got the COVID vaccine. Patient performed lab test on 29Jun2021, and 02Jul2021 blood magnesium result was unknown and blood pressure result was high. The outcome of event (Heartrate was elevated) was recovered 0n 30Jun2021 and outcome of (blood pressure increased) unknown, rest of all events were not recovered. Communication: Caller provided with Report Reference. The caller was provided with the phone number and hours of operation prior to a warm transfer.
Went for well child check 12/2 no issues flu vaccination given.  Next day developed flu like illness with fever 102.3, body aches lethargy, treated with Tylenol and Motrin, symptoms waxed and waned got significantly worse Tuesday 12/6/11 with dyspnea.  Patient went unresponsive on way to pediatrician emergent resuscitation and died 12/6/11.
1/6am tingling entire body x 5-6 hours. Then extreme fatigue after tingling stopped.  Narrative:
Patient has had an adverse anaphylactic reaction previously to penicillin. Patient was instructed to wait 30 minutes post immunization. At 28 minutes, patient reported hot feeling in central chest, swollen tongue , rapid heart rate, and odd taste in the mouth. Blood pressure reading was high 144/93  pulse 76.